Streptokinase--the drug of choice for thrombolytic therapy.
about
Skin microbiota: a source of disease or defence?Nanomedicine as a strategy to fight thrombotic diseases.Jugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical managementChanges in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone.Targeted thrombolysis strategies for neuroprotective effectEffects of organic extracts and their different fractions of five Bangladeshi plants on in vitro thrombolysisDirected Evolution of Enzymes for Industrial Biocatalysis.Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progressionShaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.Pentoxifylline Increases Antiadhesion Effect of Streptokinase on Postoperative Adhesion Formation: Involvement of Fibrinolytic Pathway.Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Screening, Cloning and Expression of Active Streptokinase from an Iranian Isolate of S.equisimilis Group C in E. coli.Proteases as therapeutics.Serine-proteases as plasminogen activators in terms of fibrinolysis.Analysis of streptokinase by validated liquid chromatography methods and correlation with an in vitro bioassay.The evolution of recombinant thrombolytics: Current status and future directionsElongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies.Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapyReprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.Purification and characterization of a new serine protease with fibrinolytic activity from the marine invertebrate, Urechis unicinctus.Streptococcus agalactiae mural infective endocarditis in a structurally normal heart.Pitfalls in screening streptococci for retrieving superior streptokinase (SK) genes: no activity correlation for streptococcal culture supernatant and recombinant SK.Liposomes for the delivery of streptokinase.An In Vitro Thrombolysis Study Using a Mixture of Fast-Acting and Slower Release Microspheres.In Vivo Anticoagulant and Thrombolytic Activities of a Fibrinolytic Serine Protease (Brevithrombolase) With the k-Carrageenan-Induced Rat Tail Thrombosis Model.Targeted delivery of thrombolytic agents: role of integrin receptors
P2860
Q24651518-9025B898-D6BC-4CF5-9DF9-7C03234AB240Q30367197-15E2E956-880F-43CE-BF93-F05308DE358EQ30452826-9B53BB2C-DB2C-4D59-92D9-EEF724692C31Q30493511-3D2DE004-295B-413A-B740-75F83449689CQ34163191-8ED777D1-94AE-4E42-931F-96D32CE2056AQ35552297-6C5CA6F0-C153-473B-A3E4-C732AA7FCB4BQ35867710-123D72A4-2780-4BEA-97DF-4AF936612D05Q35929823-8936F7BD-A52E-4363-A171-49DF1853AABDQ36204756-2E4401D1-963A-4623-A0A8-86DEB877278AQ36643690-3702192F-75AB-4AD8-A624-AED2DF071BFBQ36739647-F836686A-9855-44C4-B730-556BF09F475CQ37292063-BB75CF09-C9FF-4FEA-8E37-E77A59A48709Q37853216-19198675-E24E-4EA3-8935-374DFD4E8740Q38024834-E53E626F-D0A9-401D-A69B-B319648AE1A6Q38435106-7B2AAD04-53A6-4AEE-A368-AA75BB74CB33Q38803641-BB9C4D20-38B7-4997-8A02-AC8F9B228B41Q40053619-0E8EB2AB-0B99-4F3A-898B-BD5A7C6790BEQ41608362-0C6A3EB5-3A34-40B2-9EFC-9E15D23C17A8Q41909356-E4CCF57F-0C05-4182-8304-9339E2FC789EQ42694865-C31C368E-2785-4196-8680-75FEE6093CE4Q42745421-9DA27407-7FF6-4477-8229-FE650E3F2620Q44539916-54451DEC-8D39-43BA-A359-39C276132F3EQ49853329-299F4CAC-A2EC-4C7F-9AC9-9E8A2D995C5FQ51453425-52D8A624-52D3-4DB1-B172-C599C81B6213Q53617876-C910608A-CEE0-4B41-82A9-A6A878EEC21FQ56897486-FAD33866-DC28-40AF-8C87-07526E1F436C
P2860
Streptokinase--the drug of choice for thrombolytic therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Streptokinase--the drug of choice for thrombolytic therapy.
@ast
Streptokinase--the drug of choice for thrombolytic therapy.
@en
type
label
Streptokinase--the drug of choice for thrombolytic therapy.
@ast
Streptokinase--the drug of choice for thrombolytic therapy.
@en
prefLabel
Streptokinase--the drug of choice for thrombolytic therapy.
@ast
Streptokinase--the drug of choice for thrombolytic therapy.
@en
P2093
P2860
P1476
Streptokinase--the drug of choice for thrombolytic therapy.
@en
P2093
Adinarayana Kunamneni
Poluri Ellaiah
Thaer Taleb Abed Abdelghani
P2860
P2888
P356
10.1007/S11239-006-9011-X
P577
2007-02-01T00:00:00Z